Name: PMV Pharmaceuticals, Inc. (PMVP) Balance Sheet
Creator: FinSpry

PMV Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for PMV Pharmaceuticals, Inc. (PMVP) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	40.88	203.06	108.30	172.47	361.42
Short-Term Investments	128.58	165.35	132.76	124.70	0.00
Cash & Short-Term Investments	169.45	203.06	241.05	297.16	361.42
Accounts Receivable	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	6.20	3.17	5.13	3.30	0.88
Total Current Assets	175.66	207.41	247.01	301.29	364.76
Non-Current Assets
Property, Plant & Equipment (Net)	1.55	19.05	20.49	13.15	0.57
Long-Term Investments	13.84	25.51	2.50	16.91	0.00
Other Non-Current Assets	0.24	0.19	0.31	0.22	0.20
Total Non-Current Assets	15.63	44.74	23.30	30.28	0.77
Total Assets	191.29	252.15	270.31	331.57	365.53
Current Liabilities
Accounts Payable	6.58	13.18	3.00	3.19	6.41
Short-Term Debt	0.35	0.00	0.00	0.00	0.00
Accrued Liabilities	7.44	5.44	4.41	8.63	4.80
Other Current Liabilities	7.44	0.00	0.00	0.00	0.00
Total Current Liabilities	14.37	14.03	10.83	12.22	6.41
Non-Current Liabilities
Long-Term Debt	0.84	12.43	13.45	10.79	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	0.84	12.43	13.45	10.79	0.00
Total Liabilities	15.21	26.46	24.28	23.01	6.41
Stockholders' Equity
Retained Earnings	-368.71	-309.78	-241.04	-167.73	-109.88
Accumulated Other Comprehensive Income	0.14	0.22	-0.45	-0.08	0.00
Additional Paid-in Capital	544.65	535.47	487.52	476.36	469.00
Shares Outstanding	51.94	51.45	45.77	45.43	0.00
Total Stockholders' Equity	176.08	225.69	246.03	308.56	359.12
Total Liabilities & Equity	191.29	252.15	270.31	331.57	365.53